These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9365618)

  • 1. Study of circadian variation of cyclosporine pharmacokinetics.
    Milanian I; Ghods AJ; Mahmoudian M; Proushani-Nia F; Nejad Gashti H; Abdi E; Abbasi M
    Transplant Proc; 1997 Nov; 29(7):2930-1. PubMed ID: 9365618
    [No Abstract]   [Full Text] [Related]  

  • 2. Circadian variation of cyclosporine A in renal transplanted patients.
    Reyna Rodríguez C; Jung Cook H; González López EH; Nava A
    Rev Alerg Mex; 2004; 51(1):9-12. PubMed ID: 15119750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte-to-plasma distribution ratio of cyclosporine: a useful indicator to predict cyclosporine pharmacokinetics and physiological changes during cyclosporine monitoring.
    Shibata N; Hoshino N; Yamaji A; Park KI; Inoue H; Tomoyoshi T; Sako H; Abe H; Kodama M; Nakane Y
    Transplant Proc; 1996 Jun; 28(3):1313-5. PubMed ID: 8658674
    [No Abstract]   [Full Text] [Related]  

  • 4. A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).
    Foradori A; Pinto VM; Elberg A
    Transplant Proc; 1998 Aug; 30(5):1666-7. PubMed ID: 9723235
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of Neoral and Sandimmune preparations in renal transplant patients--improved pharmacokinetics with neoral.
    Warrens AN; Salama A; Waters JB; Lechler RI
    Transplant Proc; 1996 Aug; 28(4):2169-70. PubMed ID: 8769190
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics and renal function after conversion from standard to microemulsion formulation of cyclosporine in stable renal transplant patients.
    Gaspari F; Anedda MF; Signorini O; Amuchastegui SC; Perico N; Remuzzi G
    Transplant Proc; 1998 Aug; 30(5):1654-5. PubMed ID: 9723229
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimization of cyclosporine therapy in kidney transplantation.
    Remuzzi G; Perico N; Gaspari F
    Transplant Proc; 1998 Aug; 30(5):1673-6. PubMed ID: 9723238
    [No Abstract]   [Full Text] [Related]  

  • 8. C0/C2 cyclosporine levels monitoring in renal transplantation.
    Santana A; Guerra J; Milhomens C; Neves F; Prata MM
    Transplant Proc; 2003 May; 35(3):1072-3. PubMed ID: 12947862
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazol in stable adult kidney transplants.
    Foradori A; Mezzano S; Videla C; Pefaur J; Elberg A
    Transplant Proc; 1998 Aug; 30(5):1685-7. PubMed ID: 9723244
    [No Abstract]   [Full Text] [Related]  

  • 10. Early achievement of target cyclosporine levels during initial post-transplant period with a novel dosing strategy.
    Chueh SC; Lai MK
    Transplant Proc; 1998 Aug; 30(5):1681-2. PubMed ID: 9723242
    [No Abstract]   [Full Text] [Related]  

  • 11. Low exposure to cyclosporine is a risk factor for the occurrence of chronic rejection after kidney transplantation.
    Citterio F; Torricelli P; Serino F; Foco M; Pozzetto U; Fioravanti P; Castagneto M
    Transplant Proc; 1998 Aug; 30(5):1688-90. PubMed ID: 9723245
    [No Abstract]   [Full Text] [Related]  

  • 12. Convenience of level of cyclosporine-Neoral at time 3 to determine the area under curve in renal transplant.
    Rial MC; Frias S; Argento J; Tessler J; Casadei D
    Transplant Proc; 1997; 29(1-2):292-3. PubMed ID: 9123001
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of abbreviated AUC of cyclosporine in renal allograft recipients in a Pakistani population.
    Zafar MN; Abbas K; Naqvi A; Rizvi A
    Transplant Proc; 1999 Dec; 31(8):3304. PubMed ID: 10616486
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine A is associated with a shift of the Th1/Th2 balance in liver transplant patients.
    van den Berg AP; Twilhaar WN; Corver K; Geerts AB; Mesander G; Klompmaker IJ; Slooff MJ; The TH; de Leij LH
    Transplant Proc; 1998 Aug; 30(5):2378-9. PubMed ID: 9723510
    [No Abstract]   [Full Text] [Related]  

  • 15. Abbreviated kinetic profiles to estimate exposure to CyA in renal allograft recipients treated with Sandimmun-Neoral.
    Serafinowicz A; Gaciong Z; Majchrzak J; Baczkowska T; Nowacka E; Gradowska L; Rowiński W; Lao M
    Transplant Proc; 1997; 29(1-2):277-9. PubMed ID: 9122994
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of neoral kinetics in adult renal transplantation treated with diltiazem.
    Mezzano S; Flores C; Ardiles L; Foradori A; Elberg A
    Transplant Proc; 1998 Aug; 30(5):1660-2. PubMed ID: 9723232
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of postdose cyclosporine monitoring in living renal transplant recipients.
    Thomas R; Minz M; Singh B; Heer M; Kashyap R
    Transplant Proc; 2004 Sep; 36(7):2104. PubMed ID: 15518761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To keep a stable therapeutic level of cyclosporine during the early posttransplant period is important in graft survival.
    Ahn MS; Ha J; Yun IJ; Kim S; Lee JS; Kim S; Han JS; Ahn C; Choi Y; Cheong HI; Kim ST; Kim SJ
    Transplant Proc; 1996 Jun; 28(3):1316-7. PubMed ID: 8658675
    [No Abstract]   [Full Text] [Related]  

  • 19. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing Neoral therapeutic drug monitoring with cyclosporine trough (C(0)) and C(2) concentrations in stable renal allograft recipients.
    Einecke G; Mai I; Diekmann F; Fritsche L; Boehler T; Neumayer HH; Budde K
    Transplant Proc; 2001; 33(7-8):3102-3. PubMed ID: 11750333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.